CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo

Cancer

Volumn 119, Issue 4, 2013, Pages 729-738

  Gemei, Marica ^a   Mirabelli, Peppino ^a   Di Noto, Rosa ^a   Corbo, Claudia ^a   Iaccarino, Antonino ^a   Zamboli, Anna ^b   Troncone, Giancarlo ^a   Galizia, Gennaro ^b   Lieto, Eva ^b   Del Vecchio, Luigi ^a   Salvatore, Francesco ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

carcinoembryonic antigen related cell adhesion molecule 6; cluster of differentiation 66c; colon cancer; small interfering RNA silencing; stem cell directed therapy; stem cells

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CD133 ANTIGEN; SMALL INTERFERING RNA; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER STAGING; CANCER STEM CELL; CARCINOGENESIS; CELL CLONE; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL STRAIN CACO 2; CLINICAL ARTICLE; CLONOGENESIS; COLON; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD; CACO-2 CELLS; CELL ADHESION MOLECULES; CELL SEPARATION; COLON; COLORECTAL NEOPLASMS; FEMALE; GENE SILENCING; GLYCOPROTEINS; GPI-LINKED PROTEINS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; PEPTIDES; REFERENCE VALUES; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84873411968     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27794     Document Type: Article

References (28)

1. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer and cancer stem cells. Nature. 2001; 414: 105-111.
2. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007; 445: 111-115.
3. Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007; 104: 10158-10163.
4. Galizia G, Gemei M, Del Vecchio L, et al. Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer. Arch Surg. 2012; 147: 18-24.
5. Corbo C, Orru S, Gemei M, et al. Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and up-regulation of SRp20 that is potentially involved in tumorigenicity. Proteomics. 2012; 12: 2045-2059.
6. Elsaba TMA, Martinez-Pomares L, Robins AR, et al. The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer [serial online]. PLoS One. 2010; 5: e10714.
7. Bourseau-Guilmain E, Griveau A, Benoit JP, et al. The importance of the stem cell marker Prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells [serial online]. PLoS One. 2011; 6: e25515.
8. Subramaniam V, Vincent IR, Gilakjan M, et al. Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy. Exp Mol Pathol. 2007; 83: 332-340.
9. Du L, Wang H, He L, et al. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res. 2008; 14: 6751-6760.
10. Park CY, Tseng D, Weissman LI,. Cancer stem cell-directed therapies: recent data from the laboratory and clinic. Mol Ther. 2009; 17: 219-230.
11. Wilson BJ, Schatton T, Frank MH, et al. Colorectal cancer stem cells: biology and therapeutic implications. Curr Colorectal Cancer Rep. 2011; 7: 128-135.
12. Ilantzis C, Jothy S, Alpert LC, et al. Cell surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis. Lab Invest. 1997; 76: 703-716.
13. Duxbury MS, Ito H, Zinner MJ, et al. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene. 2004; 23: 465-473.
14. Blumenthal RD, Hansen HJ, Goldenberg DM,. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (carcinoembryonic antigen). Cancer Res. 2005; 65: 8809-8817.
15. Schozel S, Zimmerman W, Schwarzkpropf G, et al. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol. 2000; 156: 595-605.
16. Jantscheff P, Terracciano L, Lowy A, et al. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol. 2003; 21: 3638-3646.
17. Blumenthal RD, Leon E, Hansen HJ, et al. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers [serial online]. BMC Cancer. 2007; 3: 7-12.
18. Duxbury MS, Matros E, Ito H, et al. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. Ann Surg. 2004; 240: 667-674.
19. Strickland LA, Ross J, Williams S, et al. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol. 2009; 218: 380-390.
20. Perfetto SP, Chattopadhyay PK, Roederer M,. Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol. 2004; 4: 648-655.
21. Franken NA, Rodermond HM, Stap J, et al. Clonogenic assay of cells in vitro. Nat Protoc. 2006; 1: 2315-2319.
22. Andolfo I, Petrosino G, Vecchione L, et al. Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma [serial online]. BMC Cancer. 2011; 11: 126.
23. Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007; 449: 1003-1007.
24. Sangiorgi E, Capecchi MR,. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet. 2008; 40: 915-920.
25. Ilantzis C, DeMarte L, Screaton RA, et al. Deregulated expression of the human tumor marker CEA and CEA-family member CEACAM6 disrupts tissue architecture and blocks colonocytes differentiation. Neoplasia. 2002; 4: 151-163.
26. Hanenberg H, Baumann M, Quentin I, et al. Expression of the CEA gene family members NCA-50/90 and NCA-160 (CD66) in childhood acute lymphoblastic leukemias (ALLs) and in cell lines of B-cell origin. Leukemia. 1994; 8: 2127-2133.
27. Chan CH, Camacho-Leal P, Stanners CP,. Colorectal hyperplasia and dysplasia due to human carcinoembryonic antigen (CEA) family member expression in transgenic mice [serial online]. PLoS One. 2007; 2: e1353.
28. Screaton RA, Penn LZ, Stanners CP,. Carcinoembryonic antigen, a human tumor marker, cooperates with Myc and Bcl 2 in cellular transformation. Cell Biol. 1997; 137: 939-952.